Galapagos NV’s BioFocus service division has extended its collaboration with Chiesi Farmaceutici, a privately owned Italian pharmaceutical company. The extension with Chiesi is valued at EUR2.8 million. BioFocus and Chiesi began their collaboration in December 2009 and have now extended the agreement for a second time, until the end of 2012. BioFocus will provide expanded medicinal chemistry resource, biology services, and an option to perform ADME services, for an undisclosed Chiesi therapeuti...